Ubiquitination and degradation of MHC-II by Tim-3 inhibits antiviral immunity

•Tim-3 inhibits MHC-II expression and induces proteasome-dependent degradation of MHC-II during H1N1 infection in vitro.•Tim-3 promotes the K48-linked ubiquitination of MHC-II via MARCH8.•Tim-3 promotes virus immune evasion by decreasing the differentiation of the effector CD4+T cells. We previously...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cellular immunology 2025-01, Vol.407, p.104889, Article 104889
Hauptverfasser: Zhou, Jie, LV, Zhonglin, Liu, Meichen, Du, Chunxiao, Du, Lin, Gao, Zhenfang, Jiang, Ziying, Wang, Lanying, Wang, Shuohua, Liang, Meng, Xie, Shun, Li, Yuxiang, Wang, Zhiding, Li, Ge, Wei, Yinxiang, Han, Gencheng
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Tim-3 inhibits MHC-II expression and induces proteasome-dependent degradation of MHC-II during H1N1 infection in vitro.•Tim-3 promotes the K48-linked ubiquitination of MHC-II via MARCH8.•Tim-3 promotes virus immune evasion by decreasing the differentiation of the effector CD4+T cells. We previously reported that Tim-3, an immune checkpoint inhibitor, inhibits MHC-II expression, but the molecular mechanisms involved and the implications for antiviral immunity remain to be determined. Here, we found that during H1N1 infection, Tim-3 inhibits MHC-II expression in macrophages/microglia in vitro. Tim-3 interacts with MHC-II via its intracellular tail and induces proteasomal dependent degradation of MHC-II. In H1N1 infected macrophages/microglia, Tim-3 promotes the K48-linked ubiquitination of MHC-II via MARCH8, a ubiquitin E3 ligase that can be upregulated by Tim-3. In H1N1 infected mice, specific knockout of Tim-3 in macrophages leads to a decreased viral load, attenuates tissue damage and increases the survival rate. We have thus identified a novel mechanism by which Tim-3 mediates virus immune escape. Manipulating the Tim-3-MHC-II signaling pathway may provide a novel treatment for viral infections.
ISSN:0008-8749
1090-2163
1090-2163
DOI:10.1016/j.cellimm.2024.104889